Benztropine mesylate 0.5 MG Oral Tablet — RxCUI 885219
RxNorm drug concept · Semantic clinical drug
RxCUI 885219
Semantic clinical drug · SCD
● Current RxNorm concept 36 FDA products
73 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI885219
Official nameBenztropine mesylate 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped36
Package NDCs mapped73
Reported Medicaid activity (SDUD)1,313,553 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Benztropine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Benztropine helps reduce the stiffness, tremors, and movement problems that come with parkinsonism. It works by blocking certain chemical signals in the brain that are out of balan...
- What exactly is benztropine supposed to do for me?
- This medication has a long-lasting effect, so many people do best taking their full dose at bedtime — it can help you move more comfortably during the night and make it easier to g...
- Should I take my tablet in the morning or at night?
🕸️ Concept Web — How Benztropine mesylate 0.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benztropine mesylate 0.5 MG Oral Tablet
RxCUI 885219 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Benztropine
1424IN -
Benztropine mesylate
18927PIN
-
Benztropine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benztropine Oral Tablet
371038SCDF -
Benztropine mesylate Oral Tablet
2645379SCDFP -
Benztropine Oral Product
1152996SCDG -
Benztropine Pill
1152997SCDG -
Benztropine mesylate Oral Product
2662451SCDGP -
Benztropine mesylate Pill
2663440SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Benztropine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benztropine mesylate 0.5 MG
885218SCDC
-
Benztropine mesylate 0.5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benztropine mesylate 0.5 MG
SCDC · 885218 -
Benztropine Oral Tablet
SCDF · 371038 -
Benztropine mesylate Oral Tablet
SCDFP · 2645379 -
Benztropine Oral Product
SCDG · 1152996 -
Benztropine Pill
SCDG · 1152997 -
Benztropine mesylate Oral Product
SCDGP · 2662451 -
Benztropine mesylate Pill
SCDGP · 2663440
📦 FDA Products & Package NDCs
36 products · 73 package NDCs
73 package NDCs map to RxCUI 885219 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00603-2433-21 | 100 TABLET in 1 BOTTLE, PLASTIC (0603-2433-21) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00603-2433-32 | 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2433-32) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00603-2434-21 | 100 TABLET in 1 BOTTLE, PLASTIC (0603-2434-21) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00603-2434-32 | 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2434-32) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00603-2435-21 | 100 TABLET in 1 BOTTLE, PLASTIC (0603-2435-21) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00603-2435-32 | 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2435-32) | Benztropine Mesylate | Endo USA, Inc. | 2022-03-17 |
| 00615-8222-39 | 30 TABLET in 1 BLISTER PACK (0615-8222-39) | Benztropine Mesylate | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-06-06 |
| 00615-8223-39 | 30 TABLET in 1 BLISTER PACK (0615-8223-39) | Benztropine Mesylate | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-04-11 |
| 00904-7288-61 | 100 BLISTER PACK in 1 CARTON (0904-7288-61) / 1 TABLET in 1... | Benztropine Mesylate | Major Pharmaceuticals | 2023-07-11 |
| 00904-7289-61 | 100 BLISTER PACK in 1 CARTON (0904-7289-61) / 1 TABLET in 1... | Benztropine Mesylate | Major Pharmaceuticals | 2023-07-11 |
| 00904-7290-61 | 100 BLISTER PACK in 1 CARTON (0904-7290-61) / 1 TABLET in 1... | Benztropine Mesylate | Major Pharmaceuticals | 2023-07-11 |
| 10135-0813-01 | 100 TABLET in 1 BOTTLE (10135-813-01) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 10135-0813-10 | 1000 TABLET in 1 BOTTLE (10135-813-10) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 10135-0814-01 | 100 TABLET in 1 BOTTLE (10135-814-01) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 10135-0814-10 | 1000 TABLET in 1 BOTTLE (10135-814-10) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 10135-0815-01 | 100 TABLET in 1 BOTTLE (10135-815-01) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 10135-0815-10 | 1000 TABLET in 1 BOTTLE (10135-815-10) | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 2025-03-01 |
| 11534-0167-09 | 100 TABLET in 1 BOTTLE (11534-167-09) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 11534-0167-10 | 1000 TABLET in 1 BOTTLE (11534-167-10) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 11534-0168-09 | 100 TABLET in 1 BOTTLE (11534-168-09) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 11534-0168-10 | 1000 TABLET in 1 BOTTLE (11534-168-10) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 11534-0169-09 | 100 TABLET in 1 BOTTLE (11534-169-09) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 11534-0169-10 | 1000 TABLET in 1 BOTTLE (11534-169-10) | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2024-10-16 |
| 50228-0225-01 | 100 TABLET in 1 BOTTLE (50228-225-01) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 50228-0225-10 | 1000 TABLET in 1 BOTTLE (50228-225-10) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 50228-0226-01 | 100 TABLET in 1 BOTTLE (50228-226-01) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 50228-0226-10 | 1000 TABLET in 1 BOTTLE (50228-226-10) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 50228-0227-01 | 100 TABLET in 1 BOTTLE (50228-227-01) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 50228-0227-10 | 1000 TABLET in 1 BOTTLE (50228-227-10) | Benztropine Mesylate | ScieGen Pharmaceuticals Inc | 2024-11-05 |
| 62135-0141-18 | 180 TABLET in 1 BOTTLE (62135-141-18) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-09-01 |
| 62135-0141-57 | 540 TABLET in 1 BOTTLE (62135-141-57) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-09-01 |
| 62135-0142-01 | 100 TABLET in 1 BOTTLE, PLASTIC (62135-142-01) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0142-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (62135-142-10) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0142-18 | 180 TABLET in 1 BOTTLE, PLASTIC (62135-142-18) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-03-07 |
| 62135-0142-30 | 30 TABLET in 1 BOTTLE, PLASTIC (62135-142-30) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0142-57 | 540 TABLET in 1 BOTTLE, PLASTIC (62135-142-57) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-03-07 |
| 62135-0144-01 | 100 TABLET in 1 BOTTLE, PLASTIC (62135-144-01) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0144-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (62135-144-10) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0144-18 | 180 TABLET in 1 BOTTLE, PLASTIC (62135-144-18) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-03-07 |
| 62135-0144-30 | 30 TABLET in 1 BOTTLE, PLASTIC (62135-144-30) | Benztropine Mesylate | Chartwell RX, LLC. | 2021-04-30 |
| 62135-0144-57 | 540 TABLET in 1 BOTTLE, PLASTIC (62135-144-57) | Benztropine Mesylate | Chartwell RX, LLC. | 2022-03-07 |
| 67046-1205-03 | 30 TABLET in 1 BLISTER PACK (67046-1205-3) | Benztropine Mesylate | Coupler LLC | 2026-05-06 |
| 67046-1674-03 | 30 TABLET in 1 BLISTER PACK (67046-1674-3) | Benztropine Mesylate | Coupler LLC | 2026-05-01 |
| 68084-0381-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-381-01) / 1 TAB... | Benztropine Mesylate | American Health Packaging | 2009-11-09 |
| 68084-0388-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-388-01) / 1 TAB... | Benztropine Mesylate | American Health Packaging | 2010-01-04 |
| 68084-0389-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-389-01) / 1 TAB... | Benztropine Mesylate | American Health Packaging | 2013-07-01 |
| 69097-0826-02 | 30 TABLET in 1 BOTTLE (69097-826-02) | Benztropine Mesylate | Cipla USA Inc. | 2016-06-29 |
| 69097-0826-07 | 100 TABLET in 1 BOTTLE (69097-826-07) | Benztropine Mesylate | Cipla USA Inc. | 2016-06-29 |
| 69097-0826-15 | 1000 TABLET in 1 BOTTLE (69097-826-15) | Benztropine Mesylate | Cipla USA Inc. | 2016-06-29 |
| 69097-0827-02 | 30 TABLET in 1 BOTTLE (69097-827-02) | Benztropine Mesylate | Cipla USA Inc. | 2016-06-29 |
Observed labelers:
Chartwell RX, LLC. (12) ·
Cipla USA Inc. (9) ·
Endo USA, Inc. (6) ·
Leading Pharma, LLC (6) ·
Marlex PHARMACEUTICAL, INC (6) ·
QUAGEN PHARMACEUTICALS LLC (6)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.